Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Tomalino is active.

Publication


Featured researches published by M. Tomalino.


Diabetes Care | 2010

Rethink Organization to iMprove Education and Outcomes (ROMEO): A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes

Marina Trento; Silvia Gamba; Luigi Gentile; G. Grassi; V. Miselli; Gabriella Morone; Pietro Passera; Laura Tonutti; M. Tomalino; Piervincenzo Bondonio; F. R. Cavallo; Massimo Porta

OBJECTIVE A trial was performed to establish whether our group care model for lifestyle intervention in type 2 diabetes can be exported to other clinics. RESEARCH DESIGN AND METHODS This study was a 4-year, two-armed, multicenter controlled trial in 13 hospital-based diabetes clinics in Italy (current controlled trials no. ISRCTN19509463). A total of 815 non–insulin-treated patients aged <80 years with ≥1 year known diabetes duration were randomized to either group or individual care. RESULTS After 4 years, patients in group care had lower A1C, total cholesterol, LDL cholesterol, triglycerides, systolic and diastolic blood pressure, BMI, and serum creatinine and higher HDL cholesterol (P < 0.001, for all) than control subjects receiving individual care, despite similar pharmacological prescriptions. Health behaviors, quality of life, and knowledge of diabetes had become better in group care patients than in control subjects (P < 0.001, for all). CONCLUSIONS The favorable clinical, cognitive, and psychological outcomes of group care can be reproduced in different clinical settings.


Diabetic Medicine | 2008

The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care

Marina Trento; M. Tomelini; M. Basile; E. Borgo; Pietro Passera; V. Miselli; M. Tomalino; F. R. Cavallo; Massimo Porta

Aims  The locus of control theory distinguishes people (internals) who attribute events in life to their own control, and those (externals) who attribute events to external circumstances. It is used to assess self‐management behaviour in chronic illnesses. Group care is a model of systemic group education that improves lifestyle behaviour and quality of life in patients with Type 1 and Type 2 diabetes. This study investigated the locus of control in Type 1 and Type 2 diabetes and the possible differences between patients managed by group care and control subjects followed by traditional one‐to‐one care.


Diabetic Medicine | 1995

Diabetic retinopathy as a cause of blindness in the province of Turin, north-west Italy, in 1967-1991.

Massimo Porta; M. Tomalino; Santoro F; L.D. Ghigo; M. Cairo; M. Aimone; G.B. Pietragalla; Pietro Passera; Marcello Montanaro; G. M. Molinatti

Diabetes is known to be a major contributor to blindness in industrialized countries but few data are available on the situation in Italy. As an introductory step to the implementation of permanent screening for diabetic retinopathy, a search was carried out on the causes of visual loss in the provincial territory surrounding Turin, the main city of North‐West Italy. The case notes of all 4549 residents in the province who were certified blind between 1967 and 1991 were examined with regard to cause, age at onset, and year of onset of visual acuity 1/20. Diabetic retinopathy was the second commonest cause of bilateral blindness (13.1 % of cases), preceded by cataract (26.7%) and followed by myopia (11.1%), optic atrophy (8.9%), glaucoma (8.9%), retinitis pigmentosa (7.2%), and senile macular degeneration (4.1%). Diabetic retinopathy was the commonest eye disease among those who became blind between the ages of 50 and 70 and remained the leading cause of visual loss when the age groups 20 to 70 were pooled together. The incidence of diabetic retinopathy‐related blindness did not show any trend to decrease over the 25 years investigated. It is concluded that, in spite of widespread availability of facilities for its assessment and treatment, diabetic retinopathy remains a leading cause of blindness in North‐West Italy. This fully justifies the implementation of screening programmes and efficient referral chains for the early detection and prompt treatment of this complication of diabetes.


Diabetologia | 1991

The increase in albuminuria induced by exercise is not associated with preferential excretion of glycated albumin in Type 1 (insulin-dependent) diabetic patients

Paolo Cavallo-Perin; Anna Chiambretti; V. Calefato; M. Tomalino; R. Urbino; Giovanni Cecchini; Gianfranco Pagano

SummaryThe increase in urinary albumin excretion induced by acute exercise in Type 1 (insulin-dependent) diabetic patients is associated with the urinary excretion of cationic proteins. To test whether the renal excretion of glycated albumin (more anionic than non-glycated albumin) is affected by exercise, we submitted seven normoalbuminuric (albumin excretion rate < 30 mg/24 h) Type 1 diabetic patients and six well-matched healthy subjects to an exercise test (600 kpm/min for 20 min) on a bicycle ergometer, preceded and followed by a 1-h resting period. The selectivity index (renal clearance of non-glycated/glycated albumin) was not significantly different among the pre-exercise, exercise and post-exercise periods, either in the normal subjects (1.01±0.03 vs 1.08±0.06 vs 1.08±0.05) or in the diabetic patients (1.25±0.09 vs 1.20±0.07 vs 1.20+-0.06), whereas it was significantly higher (p < 0.05) in diabetic patients compared to healthy subjects during pre-exercise. These results are not consistent with the hypothesis that acute exercise may induce a preferential excretion of glycated albumin.


Diabetes Care | 2001

Group Visits Improve Metabolic Control in Type 2 Diabetes: A 2-year follow-up

Marina Trento; Pietro Passera; M. Tomalino; M Bajardi; Fulvio Pomero; Attilio Allione; Piero Vaccari; Gian Michele Molinatti; Massimo Porta


Diabetes Care | 2004

A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care

Marina Trento; Pietro Passera; E. Borgo; M. Tomalino; M Bajardi; F. R. Cavallo; Massimo Porta


Diabetologia | 2002

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial.

Marina Trento; Pietro Passera; M Bajardi; M. Tomalino; G. Grassi; E. Borgo; C. Donnola; F. R. Cavallo; Piervincenzo Bondonio; Massimo Porta


Nutrition Metabolism and Cardiovascular Diseases | 2005

A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes

Marina Trento; Pietro Passera; E. Borgo; M. Tomalino; M Bajardi; A. Brescianini; M. Tomelini; S. Giuliano; F. R. Cavallo; V. Miselli; Piervincenzo Bondonio; Massimo Porta


Diabetes & Metabolism | 1999

Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy

Massimo Porta; Rizzitiello A; M. Tomalino; Marina Trento; Pietro Passera; Minonne A; Fulvio Pomero; Silvia Gamba; Castellazzi R; Marcello Montanaro; R. Sivieri; Orsi R; Piervincenzo Bondonio; Molinatti Gm


/data/revues/12623636/00320001/77/ | 2008

Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care

Marina Trento; Pietro Passera; V. Miselli; M Bajardi; E. Borgo; M. Tomelini; M. Tomalino; F. R. Cavallo; Massimo Porta

Collaboration


Dive into the M. Tomalino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge